These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7125852)

  • 41. Methodological standards in studies evaluating the dexamethasone suppression test.
    Davies J; Hall J; McFarlane A
    Aust N Z J Psychiatry; 1984 Sep; 18(3):273-6. PubMed ID: 6593059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The dexamethasone suppression test for melancholia.
    Carroll BJ
    Br J Psychiatry; 1982 Mar; 140():292-304. PubMed ID: 7093598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuroendocrine evaluation of depression in borderline patients.
    Carroll BJ; Greden JF; Feinberg M; Lohr N; James NM; Steiner M; Haskett RF; Albala AA; DeVigne JP; Tarika J
    Psychiatr Clin North Am; 1981 Apr; 4(1):89-99. PubMed ID: 7232239
    [No Abstract]   [Full Text] [Related]  

  • 44. d-Amphetamine response and dexamethasone suppression test as predictors of treatment outcome in unipolar depression.
    Ettigi PG; Hayes PE; Narasimhachari N; Hamer RM; Goldberg S; Secord GJ
    Biol Psychiatry; 1983 Apr; 18(4):499-504. PubMed ID: 6860724
    [No Abstract]   [Full Text] [Related]  

  • 45. Cortisol suppression index: a new approach to interpreting the DST in depression.
    Bernstein JP; Chung SY; Avila KS
    J Clin Psychiatry; 1982 Dec; 43(12):476-8. PubMed ID: 7161249
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Normalization of dexamethasone test associated with social support system improvement.
    Schwartz LS
    Psychiatr J Univ Ott; 1984 Mar; 9(1):45-6. PubMed ID: 6374718
    [No Abstract]   [Full Text] [Related]  

  • 47. The dexamethasone suppression test in the identification subtypes of depression differentially responsive to antidepressants [proceedings].
    Brown WA; Haier RJ; Qualls CB
    Psychopharmacol Bull; 1981 Jan; 17(1):88-90. PubMed ID: 7232667
    [No Abstract]   [Full Text] [Related]  

  • 48. Abnormal dexamethasone tests in withdrawing alcoholic patients.
    Targum SD; Capodanno AE; Unger S; Advani M
    Biol Psychiatry; 1984 Mar; 19(3):401-5. PubMed ID: 6722229
    [No Abstract]   [Full Text] [Related]  

  • 49. [Dexamethasone test and depression].
    Syvälahti E
    Duodecim; 1982; 98(7):535-42. PubMed ID: 7084094
    [No Abstract]   [Full Text] [Related]  

  • 50. Some conceptual aspects of laboratory tests in depression.
    Davis JM; Dysken MW; Matuzas WM; Nasr SJ
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):21-6. PubMed ID: 6853456
    [No Abstract]   [Full Text] [Related]  

  • 51. DST non-suppression predicts suicide after attempted suicide.
    Jokinen J; Carlborg A; Mårtensson B; Forslund K; Nordström AL; Nordström P
    Psychiatry Res; 2007 Apr; 150(3):297-303. PubMed ID: 17316825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The sensitivity and specificity of the DST in child psychiatric disorders.
    Sellman D; Ney P
    Aust N Z J Psychiatry; 1984 Sep; 18(3):289. PubMed ID: 6593063
    [No Abstract]   [Full Text] [Related]  

  • 53. Psychobiological markers in secondary depression.
    Thase ME
    Am J Psychiatry; 1983 Jun; 140(6):816-7. PubMed ID: 6846650
    [No Abstract]   [Full Text] [Related]  

  • 54. Relationship of dexamethasone (2 mg) and plasma cortisol hypersecretion in depressive illness: clinical and neuroendocrine parameters.
    Asnis GM; Halbreich U; Sachar EJ; Nathan RS; Davies M; Novacenko H; Ostrow LC; Endicott J; Puig-Antich J
    Psychopharmacol Bull; 1982 Oct; 18(4):122-6. PubMed ID: 7156272
    [No Abstract]   [Full Text] [Related]  

  • 55. Hormonal differences between psychotic and non-psychotic melancholic depression.
    Contreras F; Menchon JM; Urretavizcaya M; Navarro MA; Vallejo J; Parker G
    J Affect Disord; 2007 Jun; 100(1-3):65-73. PubMed ID: 17098292
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The dex/CRH test--is it better than the DST?
    Watson S; Gallagher P; Smith MS; Ferrier IN; Young AH
    Psychoneuroendocrinology; 2006 Aug; 31(7):889-94. PubMed ID: 16701957
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions.
    Stewart JW; Quitkin FM; McGrath PJ; Klein DF
    J Affect Disord; 2005 Jun; 86(2-3):161-7. PubMed ID: 15935235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fluctuating postdexamethasone cortisol levels in a patient with melancholia.
    Rothschild AJ; Schatzberg AF
    Am J Psychiatry; 1982 Jan; 139(1):129-30. PubMed ID: 7055259
    [No Abstract]   [Full Text] [Related]  

  • 59. Variations in dexamethasone suppression test results: RIA values exceed CPBA.
    Robillard M; Kennedy S; Allen L; Kirshenblat D; Steiner M
    Psychiatr J Univ Ott; 1988 Sep; 13(3):122-3. PubMed ID: 3054973
    [No Abstract]   [Full Text] [Related]  

  • 60. Preliminary report on the dexamethasone suppression test in adolescents.
    Robbins DR; Alessi NE; Yanchyshyn GW; Colfer MV
    Am J Psychiatry; 1982 Jul; 139(7):942-3. PubMed ID: 7091415
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.